Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-000295
Filing Date
2021-01-06
Accepted
2021-01-06 17:26:31
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3453
  Complete submission text file 0001437749-21-000295.txt   5024
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Issuer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address (212) 531-5965
Tarnok Michael P. (Reporting) CIK: 0001413525 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32513 | Film No.: 21511815